Core Viewpoint - Neusoft Corporation is actively implementing strategic transformations focusing on AI and data value, leading to significant improvements in operational performance and market position across various sectors, particularly in healthcare and smart automotive solutions [2][3][11]. Group 1: Strategic Transformation and Performance - The company has made substantial progress in its strategic transformation, emphasizing the intelligentization of solutions and data value realization, resulting in a notable increase in net profit and cash flow [3][4]. - In 2024, the company signed new contracts worth 678 million yuan in vertical AI applications and 233 million yuan in data value-related businesses, marking a year-on-year growth of 207% [3][4]. - The company achieved a net profit of 36.13 million yuan, an increase of 111.14 million yuan year-on-year, with a main business net profit growth of 22.01% [3][4]. Group 2: Healthcare Sector Developments - Neusoft maintains the leading market share in healthcare IT solutions, focusing on high-quality reforms in public hospitals and the value realization of healthcare data [4][11]. - The company signed over 30 major healthcare project orders in 2024, enhancing its service capabilities in the healthcare sector [4][11]. - Neusoft's AI-driven healthcare solutions have been implemented in over 90 hospitals, showcasing its commitment to integrating AI with healthcare services [6][11]. Group 3: Smart Automotive Solutions - The company has developed the 8295 smart cockpit platform, achieving significant technological innovations and partnerships with major automotive manufacturers [5][22]. - In 2024, the overall shipment volume of automotive products increased by over 30%, with export-related business growing by 65% [5][24]. - Neusoft's automotive solutions have been recognized with multiple awards, including the "Best Overseas Practice Award" and "Top 10 AI Technology Partners for Chinese Automotive Enterprises" [5][24]. Group 4: Data Value and AI Integration - Neusoft is actively collaborating with various cities to build data value ecosystems, focusing on healthcare, smart cities, and government big data [8][15]. - The company has launched innovative applications in data governance and AI-driven solutions, enhancing its capabilities in the healthcare and social security sectors [15][16]. - Neusoft's cloud-native data platform has strengthened its compatibility with domestic innovations, facilitating the development of data-driven products across multiple industries [8][15]. Group 5: Recognition and Awards - The company has received numerous accolades for its contributions to the software industry and its innovative solutions in AI and healthcare [8][10]. - Neusoft was recognized as a leading enterprise in the new generation of information technology and awarded for its digital government solutions [10][28]. - The company continues to enhance its brand reputation and influence within the digital economy, receiving awards for its smart elderly care services and digital government products [9][10].

Core Viewpoint - Dongsoft Group is focusing on the intelligentization strategy for solutions in 2024, emphasizing AI and big data to enhance business innovation and achieve significant growth in new contracts [1][2]. Group 1: Business Performance - In 2024, Dongsoft signed new AI application contracts worth 678 million yuan and data value-related contracts worth 233 million yuan, representing a year-on-year growth of 207% [1]. - In Q1 2025, the company signed new AI application contracts worth 189 million yuan and data value-related contracts worth 78 million yuan, with a year-on-year growth of 54% [2]. - The AI+medical business saw a contract amount of 139 million yuan in Q1 2025, marking a year-on-year increase of 211% [2]. Group 2: Product Development - Dongsoft has launched innovative products in the fields of "AI+imaging and auxiliary diagnosis," "AI+medical assistant," and "AI+medical insurance," which are being applied in major medical institutions [3]. - The company released the "AI+medical" full series solution "Tianyi," covering eight medical industry empowerment bodies and implemented in dozens of hospitals [2][3]. - The "Flying Standard Medical Imaging Annotation Platform 5.0" has annotated 55 million images by the end of 2024, recognized as the only recommended commercial tool for AI-assisted marking by clinical experts [3]. Group 3: Strategic Acquisitions - Dongsoft's acquisition of 57% of Sire Technology has been approved by the shareholders' meeting and has passed the review by the State Administration for Market Regulation [4]. - The company is currently advancing the delivery and business change procedures related to this cash acquisition and is negotiating the purchase of the remaining 43% stake [4].